These findings, together with the absence of rare F8 variants associated with DVT, led us to speculate that the increased VWF and FVIII levels measured in DVT patients could be due to other mechanisms such as the presence of mutations in regulatory regions or other genes involved in the VWF clearance [25–27]. This evidence concerns the gene VWF and deep vein thrombosis.